| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Strategic Bus. Initiatives | VP, Strategy & Program Mgmt
1 company
Peter Brian Leone last filed a Form 4 in May 2019, as VP, Strategic Bus. Initiatives at ARWR. Peter Brian Leone's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 130,000 shares of ARWR. The ARWR filings lean toward selling, a net 131,137 shares.
Peter Brian Leone has 5 Form 4 filings on record from January 2016 to May 2019, across 2 companies: Chief Business Officer at Bicycle Therapeutics (BCYC), 2019; VP, Strategic Bus. Initiatives at Arrowhead Pharmaceuticals (ARWR), 2016–2018.
The 8 reported transactions were 3 option exercises, 2 option or other derivative awards, 2 stock awards and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $1.8M.
The only open-market sale was 131,137 shares of ARWR at an average $13.49 on October 19, 2018, about $1.8M.
Shares as reported in the last Form 4 for each company; the most recent is from May 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 19, 2018 | ARWR Arrowhead Pharmaceuticals, Inc. | VP, Strategic Bus. Initiatives | Sale+OE | 131,137 | $13.49 | $1,769,038.13 | -50.2% |